Data for ST002406   

(Analysis AN003923): Average values per metabolite and experimental factor (Units:normalized relative level)

Metabolite structureAll dataF1F2F3F4F5F6F7F8F9
1,1^-diindolylmethane
0.86 0.78 0.76 0.99 0.60 0.54 1.02 1.01 0.97
4-methoxyglucobrassicin
0.52 0.71 0.37 0.10 0.18 0.13 0.22 0.22 0.10
Brassicanal A
0.53 0.48 0.45 0.12 0.13 0.10 0.18 0.09 0.14
Brassicanate A
0.66 0.54 0.56 0.56 0.48 0.49 0.57 0.26 0.62
Glucobrassicin
0.21 0.48 0.25 0.08 0.16 0.06 0.11 0.12 0.11
Gluconasturtiin
0.17 0.27 0.20 0.18 0.65 0.28 0.12 0.16 0.10
Indole-3-carboxaldehyde
0.63 0.62 0.51 0.37 0.37 0.32 0.44 0.50 0.40
Neoglucobrassicin
0.32 0.46 0.32 0.20 0.22 0.16 0.33 0.30 0.25
Rutalexin
0.30 0.40 0.42 0.02 0.03 0.13 0.02 0.01 0.00
Syringin
0.71 0.60 0.73 0.45 0.38 0.49 0.09 0.16 0.08

Factors:

F1Developmental stage (DPI):day 14 | Silicon treatment [g]:0.0
F2Developmental stage (DPI):day 14 | Silicon treatment [g]:0.5
F3Developmental stage (DPI):day 14 | Silicon treatment [g]:1.0
F4Developmental stage (DPI):day 21 | Silicon treatment [g]:0.0
F5Developmental stage (DPI):day 21 | Silicon treatment [g]:0.5
F6Developmental stage (DPI):day 21 | Silicon treatment [g]:1.0
F7Developmental stage (DPI):day 7 | Silicon treatment [g]:0.0
F8Developmental stage (DPI):day 7 | Silicon treatment [g]:0.5
F9Developmental stage (DPI):day 7 | Silicon treatment [g]:1.0
  logo